Screening for circulating tumor-related mitochondrial DNA in the serum of patients with oral cancer by high-resolution melting curve analysis

DOI Web Site 52 References
  • UZAWA Katsuhiro
    Division of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital
  • YAMATOJI Masanobu
    Division of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital
  • KASAMATSU Atsushi
    Division of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital
  • SAKAMOTO Yosuke
    Division of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital
  • OGAWARA Katsunori
    Division of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital
  • SHIIBA Masashi
    Division of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital
  • TANZAWA Hideki
    Division of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital

Bibliographic Information

Other Title
  • 高解像度融解曲線分析による口腔癌患者末梢血清中における 腫瘍由来ミトコンドリアDNA の解析
  • コウカイゾウド ユウカイ キョクセン ブンセキ ニ ヨル コウクウガン カンジャ マッショウ ケッセイ チュウ ニ オケル シュヨウ ユライ ミトコンドリア DNA ノ カイセキ

Search this article

Abstract

Although the status of surgical margins and regional lymph node metastases are relevant prognostic factors in oral squamous cell carcinoma （OSCC）, local recurrences, distant metastases （r/m）, or both have occurred in a subset of OSCC patients with histologically negative margins/lymph nodes.The principle objective of our study was to assess the possible monitoring of such OSCC cases by quantitative real-time PCR combined with high-resolution melting curve analysis （qPCR-HRMA） for circulating free mitochondrial DNA （mtDNA）, which has copy numbers hundreds to thousands times higher than those of genomic DNA （gDNA） in each cell. mtDNA from normal and tumorous tissues and serum mtDNA obtained at two time points （pre-surgery, and 4 weeks post-surgery） from 43 patients （34 r/m-negative cases and 9 r/m-positive cases） were examined for the D-loop region at position 68 of human mtDNA genome. On qPCR-HRMA, we found that mutant mtDNA was identified in the samples from tumorous tissues at much higher concentrations than in samples from corresponding normal tissues. Furthermore, 67 ％ of r/m-positive cases showed higher amounts of mtDNA （＞50 ％） in their tumor tissues as compared with the r/m-negative group. On blood tests, all serum mtDNA samples obtained 4 weeks after surgery in r/m-positive cases, except for one case, maintained high amounts of mutant mtDNA.In conclusion, tumor-specific mitochondrial mutations in the sera of OSCC patients can be successfully identified using qPCR-HRMA, and this technique has potential application for the surveillance of patients after tumor resection.

Journal

References(52)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top